USP22 stabilizes PPARγ to increase ACC and ACLY expression, which leads to abnormal lipid metabolism, promoting lipid accumulation and tumorigenesis in HCC cells (this process is accompanied by Akt activation). The gene discussed is USP22; the disease is hepatocellular carcinoma.